Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > 👀Fud Before no sales &now there been essentially no sales😉
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(87)
•••
Comment by G1945Von Nov 14, 2024 6:40am
30 Views
Post# 36312143

RE:RE:RE:RE:👀Fud Before no sales &now there been essentially no sales😉

RE:RE:RE:RE:👀Fud Before no sales &now there been essentially no sales😉
GrahamB wrote: Jopatchie says" cardiac MRI.
The BEST automation and analysis of the PLANET GEN3EHO   https://ascendcv.com/
Fud Before no sales &now there been essentially no sales"


What you say is FUD is Facts Uncover Deceit 

Of what I say is untrue-PROVE IT

There have been no significant sales-only 30,000-50000
on millions of costs 

The question is :If this is as you say the best AI cardiac imaging -why have there been so few sales?


Graham, it sure looks like Jopat got your goat. Where are you going with all of this nonsense? Quit while you're ahead and preserve some self-respect.

You really got it in for Ventripoint. The only conclusion I can make of your disdain for it is that you must have dropped a bundle on it years back and it's your mission to see it fail. :)


G1945V

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities